This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded in part by Abiomed.
Reference
Le Guyader A, et al. Budget Impact Associated with the Introduction of the Impella 5.0 Mechanical Circulatory Support Device for Cardiogenic Shock in France. ClinicoEconomics and Outcomes Research : 19 Jan 2021. Available from: URL: https://doi.org/10.2147/CEOR.S278269
Rights and permissions
About this article
Cite this article
Budget impact of using Impella 5.0 device for cardiogenic shock: savings projected in France. PharmacoEcon Outcomes News 871, 5 (2021). https://doi.org/10.1007/s40274-021-7443-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7443-3